Takeda Pharmaceutical (TAK) News Today $14.29 +0.41 (+2.95%) As of 04/14/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Takeda Completes Significant Share Repurchase in March 2025April 14 at 6:35 AM | tipranks.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Stock Holdings Decreased by Federated Hermes Inc.Federated Hermes Inc. decreased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 19.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 435,034 shares of the company's stock after selling 107,719 shares duringApril 14 at 4:31 AM | marketbeat.comRenaissance Technologies LLC Trims Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Renaissance Technologies LLC reduced its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,079April 13 at 5:43 AM | marketbeat.comChina Approves First Hemophilia B Gene Therapy by Belief BioMed and TakedaApril 11, 2025 | msn.comNMPA approves BBM and Takeda China’s haemophilia B therapyApril 11, 2025 | finance.yahoo.comPharma Stocks Tumble After Trump Threatens Tariffs on MedicinesApril 9, 2025 | wsj.comBioInvent International: BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3April 8, 2025 | finanznachrichten.deAmerican Century Companies Inc. Purchases 17,103 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)American Century Companies Inc. grew its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 6.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 301,087 shares of the company's stock afApril 7, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Sets New 1-Year High - Should You Buy?Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - Time to Buy?April 5, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Sei Investments Co.Sei Investments Co. lowered its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 29.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 222,887 shares of the company's stock after selling 93,071 shares during theApril 5, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Rating Increased to Overweight at Morgan StanleyMorgan Stanley raised Takeda Pharmaceutical from an "equal weight" rating to an "overweight" rating in a report on Wednesday.April 4, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Sells 419,019 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Arrowstreet Capital Limited Partnership reduced its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional invApril 3, 2025 | marketbeat.comRaymond James Financial Inc. Invests $1.45 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James Financial Inc. bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 109,317 shares of the company's stock, valued at approximately $1,447,April 3, 2025 | marketbeat.comTakeda upgraded to Overweight from Equal Weight at Morgan StanleyApril 2, 2025 | markets.businessinsider.comHarmony Biosciences Names Adam Zaeske as Chief Commercial OfficerMarch 30, 2025 | msn.comTakeda Canada says Health Canada expands marketing authorization for HyQviaMarch 28, 2025 | markets.businessinsider.comCharles Schwab Investment Management Inc. Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Charles Schwab Investment Management Inc. boosted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 35.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 253,551 shares of the comMarch 28, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Time to Buy?Takeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Should You Buy?March 25, 2025 | marketbeat.comSummit Global Investments Has $9.66 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Summit Global Investments lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 75.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 729,200 shares of the comMarch 23, 2025 | marketbeat.com69,083 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Bought by Boston PartnersBoston Partners bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 69,083 shares of the company's stoMarch 23, 2025 | marketbeat.comNatixis Advisors LLC Acquires 21,539 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Natixis Advisors LLC lifted its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 4.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 478,579 shares of theMarch 23, 2025 | marketbeat.comSignaturefd LLC Raises Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Signaturefd LLC boosted its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 43.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,097 shares of the cMarch 21, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - What's Next?Takeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Time to Buy?March 18, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Position Lowered by Brandes Investment Partners LPBrandes Investment Partners LP decreased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 5.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,039,585 shares of the company's stock after selling 192,019 sharMarch 16, 2025 | marketbeat.comJapan union group says gained hefty average 2025 pay hike, albeit less than last yearMarch 14, 2025 | msn.comMajor Japan union group says agreements struck for average 5.37% pay hikeMarch 13, 2025 | msn.comTakeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit HeadwindsMarch 13, 2025 | seekingalpha.comCallan Family Office LLC Buys Shares of 19,924 Takeda Pharmaceutical Company Limited (NYSE:TAK)Callan Family Office LLC bought a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 19,924 shares of the company's stock, vMarch 11, 2025 | marketbeat.comMass. man gets prison time for defrauding Takeda Pharmaceutical Co. of $2.3MMarch 11, 2025 | msn.comNaviter Wealth LLC Has $228,000 Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Naviter Wealth LLC cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 79.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,227 shares of the company's stock after selling 68,248 shares during the period. NavMarch 10, 2025 | marketbeat.comUS Bancorp DE Has $1.65 Million Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)US Bancorp DE increased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 21.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 124,332 shares of the company's sMarch 9, 2025 | marketbeat.comFisher Asset Management LLC Buys New Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK)Fisher Asset Management LLC bought a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 41,334 shares of the company's stock, valued atMarch 7, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Reaches New 1-Year High - What's Next?Takeda Pharmaceutical (NYSE:TAK) Reaches New 1-Year High - Time to Buy?March 6, 2025 | marketbeat.comMolecular Glues Competitive Landscape 2025: Exploring 65+ Drugs and 50+ Biotech Players in the Molecular Glue SpaceMarch 6, 2025 | finance.yahoo.comOppenheimer Asset Management Inc. Reduces Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Oppenheimer Asset Management Inc. decreased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 70.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,051 shares of the compaMarch 5, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Trading Up 3.1% - Should You Buy?Takeda Pharmaceutical (NYSE:TAK) Stock Price Up 3.1% - Still a Buy?March 4, 2025 | marketbeat.comSanctuary Advisors LLC Sells 40,570 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Sanctuary Advisors LLC lessened its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 57.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,451 shares of the company's stock after sMarch 4, 2025 | marketbeat.comProtagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia VeraMarch 3, 2025 | businesswire.comMETiS Pharmaceuticals Appoints Mark Herbert as Chief Business OfficerMarch 3, 2025 | finance.yahoo.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by QRG Capital Management Inc.QRG Capital Management Inc. lifted its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 16.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 329,644 shares of the company's stock aMarch 1, 2025 | marketbeat.comIs Takeda Pharmaceutical Company Limited (TAK) the Best Low Price Pharma Stock to Invest In Right Now?February 27, 2025 | msn.comTakeda announces EMA approval for Takhzyro two mL pre-filled pen optionFebruary 24, 2025 | markets.businessinsider.comThe European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)February 24, 2025 | prnewswire.comTrump Set To Break WTO Rules With Potential Pharma TariffsFebruary 20, 2025 | seekingalpha.comPetri Dish: One Boston biotech shuts down, another bags $90MFebruary 20, 2025 | bizjournals.comHow the owner of Rebelle in Kendall Square traded in beakers for bagelsFebruary 19, 2025 | bizjournals.comIs Takeda Pharmaceutical Company Limited (TAK) the Best Japanese Stock to Buy in 2025?February 15, 2025 | insidermonkey.comVan ECK Associates Corp Grows Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Van ECK Associates Corp grew its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 1.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,210,428 shares of the companyFebruary 15, 2025 | marketbeat.comStrong Q3, Improved Guidance Are Signs Takeda Pharmaceutical May Be UndervaluedJanuary 31, 2025 | seekingalpha.comTakeda announces appointment of Julie Kim as CEOJanuary 31, 2025 | msn.com Remove Ads Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.490.80▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼74▲TAK Articles Average Week Remove Ads Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today ARGX News Today ONC News Today BNTX News Today TEVA News Today ITCI News Today SMMT News Today GMAB News Today RDY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
